MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Koreabiomed.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Koreabiomed.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Koreabiomed.com most likely does not offer any adult content.
Audience
-
Bounce rate
-
Time on site
01:40
AVG
-
Gender
Men
37.5%
Women
55.5%
Popular pages
-
Korea Biomedical Review’s 2022 recap < Special < Article - KBR
On all counts, 2022 marked yet another memorable year for Korea’s bioindustry. Stories related to Covid-19 regarding quarantine and mask mandates garnered a lot of interest from our viewers as quarant...
-
Access Bio, PharmGen Science to develop biosimilar Covid-19 vaccine |
Access Bio, PharmGen Science to develop biosimilar Covid-19 vaccine 2021-09-23 Shim Hyun-tai Access Bio signed an agreement with PharmGen Science and New Jersey’s IVY Pharma to jointly develop a b...
-
‘Korea's biopharma industry needs more Innovation to stand out among competitors’ |
‘Korea's biopharma industry needs more Innovation to stand out among competitors’ 2023-06-11 Lee Han-soo BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- As the 2023 BIO In...
-
IVI/WHO biomanufacturing trainees receive technical boost from Korean bioindustry |
IVI/WHO biomanufacturing trainees receive technical boost from Korean bioindustry 2022-11-14 Marianne Chang The International Vaccine Institute (IVI) completed the second week of the three-week-lo...
-
Korean companies set high expectations for microbiome industry |
Korean companies set high expectations for microbiome industry 2023-05-18 Marianne Chang Korea has already cemented its position as a leader in Asia with its fast-growing microbiome therapeutics f...
-
‘Bio and medical R&D’s paradigm changes to AI’ |
‘Bio and medical R&D’s paradigm changes to AI’ 2023-01-02 Jeong Min-jun “Research and development in medical and biopharmaceutical fields have been made through scientists’ trials and error in the...